🔍

CHEMPLASTS - Chemplast Sanmar

📊 NSE: CHEMPLASTS 🏢 Chemicals 📅 Last Updated: 12/13/2025 21:00

📢 Recent Corporate Announcements

Chemplast Sanmar Q3 FY26: Revenue Falls 21% to ₹835 Cr with ₹119 Cr Net Loss

🔴 NEGATIVE ⭐ 8/10

EARNINGS 📅 16 Feb 2026, 07:22 PM

Chemplast Sanmar reported a challenging Q3 FY26 with consolidated revenues declining 21% YoY to ₹835 crores and a net loss of ₹119 crores. The performance was hit by a combination of weather-related production disruptions, pricing pressure from imports, and regulatory setbacks regarding anti-dumping duties. Despite the loss, management highlighted a recovery in PVC prices starting January 2026 and the positive impact of China withdrawing its 13% export tax rebate. The company is also undergoing a leadership transition, with MD Ramkumar Shankar stepping down in April 2026.

Consolidated revenue dropped 21% YoY to ₹835 crores, leading to a net loss of ₹119 crores for the quarter.
Specialty Chemicals segment saw a 13% YoY volume increase, contributing 40% to the total revenue mix.
Suspension PVC business was impacted by the non-implementation of anti-dumping duties and rescinded Quality Control Orders.
R32 refrigerant gas expansion of 14 KTPA is underway, with the first 2 KTPA swing plant expected by the end of Q4 FY26.
Management maintains a long-term revenue guidance of ₹1,000 crores for the Custom Manufactured Chemicals division by FY27-28.

💡 Investors should closely monitor PVC price spreads and the successful ramp-up of the R32 and CMC expansion projects to gauge a return to profitability. The impact of the Chinese export tax rebate withdrawal in April 2026 will be a critical catalyst for domestic margin recovery.

Chemplast Sanmar Releases Q3 FY26 Earnings Call Audio Recording

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 09 Feb 2026, 06:52 PM

Chemplast Sanmar Limited has officially released the audio recording of its earnings conference call held on February 9, 2026. The call focused on the company's unaudited standalone and consolidated financial results for the third quarter and the nine-month period ending December 31, 2025. This disclosure is a standard regulatory requirement under SEBI Listing Regulations to ensure transparency for all shareholders. Investors can access the full recording via the company's investor relations website to understand management's commentary on operational performance.

Audio recording of the earnings call held on February 9, 2026, is now publicly available.
The call covered financial performance for Q3 and the nine months ended December 31, 2025.
Recording is accessible on the official company website under the earning call transcripts section.
The filing complies with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

💡 Investors should listen to the recording to gain insights into management's outlook on the PVC and specialty chemicals market. No immediate trading action is required based on this administrative disclosure.

Chemplast Sanmar Q3 FY26: Revenue Drops 21% YoY to ₹835 Cr with Net Loss Widening to ₹119 Cr

🔴 NEGATIVE ⭐ 8/10

EARNINGS 📅 08 Feb 2026, 04:45 PM

Chemplast Sanmar reported a challenging Q3 FY26, with consolidated revenue declining 21% YoY to ₹835 Cr and a net loss of ₹119 Cr. The performance was severely impacted by pricing pressures in the Suspension PVC segment due to cheap imports and a global slowdown in the agrochemical sector affecting the Custom Manufacturing division. Despite the losses, management is optimistic about FY27, citing the withdrawal of Chinese export tax rebates and the upcoming commissioning of new R32 refrigerant gas and specialty chemical capacities. EBITDA margins turned negative at -7% for the quarter compared to 3% in the same period last year.

Consolidated Revenue for Q3 FY26 fell 21% YoY to ₹835 Cr from ₹1,058 Cr in Q3 FY25.
Reported an EBITDA loss of ₹57 Cr in Q3 FY26 against a profit of ₹32 Cr in the previous year.
Net Loss widened significantly to ₹119 Cr for the quarter compared to a loss of ₹49 Cr in Q3 FY25.
9M FY26 EBITDA plummeted 98% YoY to ₹4 Cr, reflecting severe margin compression across product lines.
R32 refrigerant gas expansion to 14 ktpa and MPB-3 Phase 3 projects are on track for completion in Q4 FY26.

💡 Investors should exercise caution as the company continues to report significant losses and faces pricing headwinds in its core PVC and caustic soda segments. While the upcoming capacity expansions and regulatory shifts in China offer a potential recovery path in FY27, it is advisable to wait for signs of bottoming out in margins before increasing exposure.

Chemplast Sanmar Q3 FY26 Standalone Revenue Drops 14% YoY; Reports Net Loss of ₹56.50 Cr

🔴 NEGATIVE ⭐ 8/10

EARNINGS 📅 07 Feb 2026, 02:36 PM

Chemplast Sanmar reported a weak performance for the quarter ended December 31, 2025, with standalone revenue from operations declining to ₹504.34 crore from ₹585.92 crore in the same quarter last year. The company posted a standalone net loss of ₹56.50 crore, a significant deterioration compared to the ₹29.75 crore loss in Q3 FY25 and a sharp reversal from the profit reported in the preceding quarter. Total expenses remained high at ₹583.44 crore, consistently exceeding total income. For the nine-month period, the standalone net loss has widened significantly to ₹120.45 crore compared to a loss of ₹40.36 crore in the previous year.

Standalone revenue from operations fell 13.9% YoY to ₹504.34 crore in Q3 FY26.
Reported a standalone net loss of ₹56.50 crore for the quarter versus a loss of ₹29.75 crore in the year-ago period.
Nine-month standalone net loss widened to ₹120.45 crore from ₹40.36 crore in 9M FY25.
Total expenses for the quarter stood at ₹583.44 crore, resulting in a loss before tax of ₹76.73 crore.
Recorded a one-time incremental impact of ₹1.89 crore due to the assessment of New Labour Codes.

💡 Investors should exercise caution as the company continues to face margin pressure and widening losses in its speciality chemicals business. Closely monitor the management's commentary on demand recovery and the impact of global chemical pricing on their bottom line.

Chemplast Sanmar Schedules Q3 & 9M FY26 Earnings Call for February 9, 2026

🟡 NEUTRAL ⭐ 4/10

ROUTINE 📅 03 Feb 2026, 06:21 PM

Chemplast Sanmar Limited has announced its earnings conference call to discuss the financial and operational performance for the third quarter and nine months ended December 31, 2025. The call is scheduled for Monday, February 9, 2026, at 12:00 Noon IST. Senior management, including the Managing Director and CFO, will be present to address queries. This event is a standard procedure following the conclusion of the fiscal quarter to provide transparency to shareholders.

Earnings call scheduled for February 9, 2026, at 12:00 Noon IST.
Management participants include MD Ramkumar Shankar and CFO N Muralidharan.
Discussion will focus on Q3 and 9M FY26 operational and financial performance.
Specific insights expected from the Custom Manufactured Chemicals Division head.
International dial-in options provided for investors in HK, Singapore, UK, and USA.

💡 Investors should mark the date to listen for management commentary on PVC price trends and the growth of the specialty chemicals segment. No immediate action is required until the actual financial results are released.

Chemplast Sanmar Clarifies No Undisclosed Info Behind Recent Stock Volatility

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 14 Jan 2026, 11:42 AM

Chemplast Sanmar Limited has issued a formal clarification to the National Stock Exchange regarding recent significant movements in its share price and trading volume. The company stated that it has no undisclosed price-sensitive information or material events that could impact its operations or performance. This response follows a surveillance query from the NSE dated January 13, 2026. As per the filing, all relevant disclosures under SEBI regulations have already been made public, suggesting the recent volatility is market-driven.

Responded to NSE surveillance query Ref. No: NSE/CM/Surveillance/16338 dated January 13, 2026
Company confirms no undisclosed material information exists under Regulation 30 of SEBI LODR
Clarification issued on January 14, 2026, regarding recent spurt in trading volume and price
Management maintains that all price-sensitive information is already in the public domain

💡 Investors should exercise caution and avoid speculative trading based solely on volume spurts, as the company has confirmed no new fundamental developments. Focus on upcoming quarterly results and sector trends for long-term decision making.

Chemplast Sanmar Submits SEBI Reg 74(5) Compliance Certificate for Q3 FY26

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 13 Jan 2026, 05:25 PM

Chemplast Sanmar Limited has filed its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The document confirms that the Registrar and Share Transfer Agent, KFin Technologies, has processed all dematerialization and rematerialization requests for the quarter ended December 31, 2025. This is a standard regulatory procedure to ensure that shareholding records are accurately maintained and reported to the stock exchanges. The filing indicates the company is in compliance with basic administrative requirements.

Compliance certificate submitted for the quarter ended December 31, 2025.
Confirmation received from Registrar and Share Transfer Agent (RTA), KFin Technologies Limited.
Adherence to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
Verification that all dematerialized/rematerialized securities were reported to BSE and NSE.

💡 No action is required as this is a routine administrative filing. Investors should continue to monitor the company's upcoming quarterly financial results for operational performance.

Chemplast Sanmar Appoints S Ganeshkumar as MD for 3 Years Effective April 2026

🟡 NEUTRAL ⭐ 7/10

MANAGEMENT 📅 10 Jan 2026, 01:06 PM

Chemplast Sanmar Limited has announced a planned leadership transition where Mr. S Ganeshkumar will take over as Managing Director for a three-year term starting April 1, 2026. The current MD, Mr. Ramkumar Shankar, will serve a brief two-month extension until March 31, 2026, to ensure a smooth handover. Additionally, the company has reappointed four independent directors for a second five-year term, signaling continuity in corporate governance. Mr. Ganeshkumar brings extensive experience from TCI Sanmar Chemicals and Raymond Limited, which is expected to support the company's long-term strategic goals.

Mr. S Ganeshkumar appointed as Managing Director for a 3-year term starting April 1, 2026.
Current MD Mr. Ramkumar Shankar granted a 2-month extension from February 1, 2026, to March 31, 2026.
Four Independent Directors reappointed for a second 5-year term beginning April 26, 2026.
Incoming MD has over 30 years of experience, including leadership roles at TCI Sanmar Chemicals and Raymond Limited.

💡 Investors should view this as a well-planned succession that ensures stability; no immediate action is required as the transition is over a year away.

Chemplast Sanmar Appoints S Ganeshkumar as MD; Reappoints 4 Independent Directors

🟡 NEUTRAL ⭐ 7/10

MANAGEMENT 📅 10 Jan 2026, 12:56 PM

Chemplast Sanmar has announced a leadership transition with Mr. S Ganeshkumar appointed as Managing Director for a 3-year term starting April 1, 2026. The current MD, Mr. Ramkumar Shankar, will serve a brief 2-month extension until March 31, 2026, to facilitate a smooth handover at the close of the financial year. Furthermore, the board has approved the reappointment of four Independent Directors for a second five-year term beginning April 26, 2026. These appointments are subject to shareholder approval and aim to ensure long-term governance stability.

Mr. S Ganeshkumar appointed as Managing Director for a 3-year term effective April 1, 2026
Current MD Mr. Ramkumar Shankar to step down on March 31, 2026, after a 2-month extension
Four Independent Directors reappointed for a second consecutive 5-year term starting April 26, 2026
Incoming MD S Ganeshkumar currently serves as CEO and MD of TCI Sanmar Chemicals S.A.E., Egypt

💡 Investors should view this as a planned leadership transition with a focus on continuity, as the new MD comes from within the Sanmar group ecosystem. No immediate action is required, but monitoring the transition's impact on operational execution in FY27 is advised.

Chemplast Sanmar to Close Trading Window from Jan 1, 2026 for Q3 Results

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 26 Dec 2025, 11:07 AM

Chemplast Sanmar Limited has announced the closure of its trading window starting January 1, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations. This closure is ahead of the upcoming announcement of the company's unaudited financial results for the quarter and nine months ending December 31, 2025. The restriction applies to all designated persons and their immediate relatives. The window will remain closed until 48 hours after the financial results are officially disclosed to the stock exchanges.

Trading window closure begins on Thursday, January 1, 2026.
Closure pertains to the financial results for the quarter and nine months ending December 31, 2025.
Restriction applies to Designated Persons and their immediate relatives under the Company's Code of Conduct.
The window will reopen two clear trading days after the results are communicated to the exchanges.

💡 This is a routine regulatory announcement with no direct impact on the stock's valuation. Investors should monitor the company's upcoming earnings release for actual performance indicators.

View All CHEMPLASTS Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Specialty Chemicals grew 10% YoY to INR 726 Cr in H1 FY26, driven by new Paste PVC capacity. Value-added Chemicals declined 9% YoY to INR 276 Cr due to pricing pressure. Suspension PVC remained flat at INR 1,131 Cr.

Geographic Revenue Split

Not disclosed in available documents, though the company mentions expanding into global markets and domestic demand shifts.

Profitability Margins

Consolidated EBITDA margin for H1 FY26 was 3%, a significant drop from 7% in H1 FY25. FY24-25 consolidated loss after tax was INR 110.36 Cr, an improvement from a loss of INR 158.43 Cr in FY23-24.

EBITDA Margin

EBITDA margin for H1 FY26 stood at 3%, down from 7% YoY. EBITDA for H1 FY26 was INR 60 Cr, representing a 60% YoY decrease from INR 150 Cr.

Capital Expenditure

Phase II expansion of CMC division completed in FY24-25. Phase 3 of MPB 3 and civil works for MPB 4 are progressing with expected completion in Q3 FY26 and Q4 FY26 respectively.

Credit Rating & Borrowing

Finance costs increased 31% to INR 235.88 Cr in FY24-25 from INR 180.52 Cr due to post-capitalisation impact of project loans. Consolidated net debt stood at INR 1,319 Cr as of September 30, 2025.

⚙️ Operational Drivers

Raw Materials

Hazardous chemicals and commodity-linked inputs including those for PVC and Hydrogen Peroxide production. Specific percentage of total cost per material is not disclosed.

Import Sources

Not disclosed in available documents, though the company notes vulnerability to geopolitical issues affecting supply chains.

Capacity Expansion

Hydrogen Peroxide reached record sales of 28,390 MT in FY24-25. CMC division has 17 products commercialized with new capacities in MPB 3 and MPB 4 expected to ramp up in late FY26.

Raw Material Costs

Raw material costs are subject to commodity price swings and currency fluctuations. The company uses hedging and sourcing diversification to mitigate these risks.

Manufacturing Efficiency

The company focuses on cost leadership and operational efficiency to protect profitability in a softening pricing environment. Most plants hold Five Star ratings from the British Safety Council.

📈 Strategic Growth

Expected Growth Rate

12.40%

Growth Strategy

Growth will be achieved through the commercialization of a diversified product pipeline in the CMC division (17 products currently), capacity expansion in Paste PVC at Cuddalore, and the completion of MPB 3 and MPB 4 blocks by Q4 FY26 to broaden the customer base in agrochemicals and life sciences.

Products & Services

Specialty Paste PVC resin, Suspension PVC, Custom Manufactured chemicals (intermediates and active ingredients), Caustic Soda, Chloromethanes, Hydrogen Peroxide, and Refrigerant gases.

Brand Portfolio

Chemplast Sanmar, Sanmar Group.

New Products/Services

17 products commercialized in CMC with several more in the pipeline; new Paste PVC plant at Cuddalore is already driving 10% growth in Specialty Chemicals.

Market Expansion

Targeting high-growth sectors such as agrochemicals and life sciences through custom manufacturing engagements.

Market Share & Ranking

#1 manufacturer of Specialty Paste PVC in India and 2nd largest producer of Suspension PVC in India.

Strategic Alliances

Long-standing partnerships (15+ years) with global originator and innovator companies in the CMC segment.

🌍 External Factors

Industry Trends

The Indian Specialty Chemicals industry is projected to grow at a CAGR of 12.4% through 2025. There is a significant shift toward sustainability and zero-liquid discharge manufacturing.

Competitive Landscape

Facing intense competition from new entrants in the Hydrogen Peroxide market and low-priced imports from the EU in the PVC segment.

Competitive Moat

Moat is built on market leadership in Paste PVC, a highly integrated closed-loop manufacturing process, and 15-year relationships with global innovators which are difficult for new entrants to replicate.

Macro Economic Sensitivity

Highly sensitive to global supply shifts and commodity price cycles, particularly in the PVC and Hydrogen Peroxide markets.

Consumer Behavior

Rising demand for eco-friendly products in healthcare and paper & pulp is driving growth in the Hydrogen Peroxide segment.

Geopolitical Risks

Geopolitical shifts, such as unrest in Bangladesh, have led to an influx of lower-priced imports into the Indian domestic market.

⚖️ Regulatory & Governance

Industry Regulations

Anti-Dumping Duty (ADD) on PVC imports from certain regions; Quality Control Orders (QCO) and ongoing ADD investigations into EU imports (decision expected Q2 FY26).